Poster
gastric canceroncologyphase III
ASCO 2024 Poster: Tislelizumab Plus Chemotherapy vs Chemotherapy Alone in HER2-Negative Gastric Cancer
A conference poster presented at ASCO 2024 summarising the RATIONALE-305 phase III data in first-line HER2-negative gastric or gastro-oesophageal junction adenocarcinoma. Designed for a 90-second walk-by read time with clear hierarchy and selective data visualisation.